Proline derivatives having affinity for the calcium channel alpha-2-delta subunit

Details for Australian Patent Application No. 2003269411 (hide)

Owner Pfizer Inc.

Inventors Rawson, David James

Agent Spruson & Ferguson

Pub. Number AU-B-2003269411

PCT Number PCT/IB03/04697

PCT Pub. Number WO2004/039367

Priority 0225379.7 31.10.02 GB

Filing date 22 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 18 June 2009

International Classifications

A61K 31/401 (2006.01) - Proline

A61K 31/00 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 0225379.7 31.10.02 GB

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2003269411

18 June 2009 Application Accepted

  Published as AU-B-2003269411

15 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269412-INTRAOCULAR LENS FOR INHIBITING PCO AND ACO

2003269410-DOMAIN EXPANSION ROM MEDIA WITH ADAPTED DOMAIN SHAPE FOR IMPROVED READOUT